Skip to Content

M I 100 (Imatinib Mesylate 100 mg)

Pill with imprint M I 100 is Orange, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Mylan Pharmaceuticals Inc..

Imatinib is used in the treatment of gastrointestinal stromal tumor; chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M I 100

Imatinib Mesylate

Imprint:
M I 100
Strength:
100 mg
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2245

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide